Found: 28
Select item for more details and to access through your institution.
Rare and novel RUNX1 fusions in myeloid neoplasms: A single‐institute experience.
- Published in:
- Genes, Chromosomes & Cancer, 2021, v. 60, n. 2, p. 100, doi. 10.1002/gcc.22901
- By:
- Publication type:
- Article
The prognosis and durable clearance of RAS mutations in patients with acute myeloid leukemia receiving induction chemotherapy.
- Published in:
- American Journal of Hematology, 2021, v. 96, n. 5, p. E171, doi. 10.1002/ajh.26146
- By:
- Publication type:
- Article
Genomic and clinical characterization of B/T mixed phenotype acute leukemia reveals recurrent features and T‐ALL like mutations.
- Published in:
- American Journal of Hematology, 2018, v. 93, n. 11, p. 1358, doi. 10.1002/ajh.25256
- By:
- Publication type:
- Article
Role of flow cytometric immunophenotyping in the diagnosis of breast implant‐associated anaplastic large cell lymphoma: A 6‐year, single‐institution experience.
- Published in:
- Cytometry. Part B, 2024, v. 106, n. 2, p. 117, doi. 10.1002/cyto.b.22162
- By:
- Publication type:
- Article
Highly sensitive single tube B‐lymphoblastic leukemia/lymphoma minimal/measurable residual disease test robust to surface antigen directed therapy.
- Published in:
- Cytometry. Part B, 2023, v. 104, n. 4, p. 279, doi. 10.1002/cyto.b.22120
- By:
- Publication type:
- Article
Mature B‐ and plasma‐cell flow cytometric analysis: A review of the impact of targeted therapy.
- Published in:
- Cytometry. Part B, 2023, v. 104, n. 3, p. 224, doi. 10.1002/cyto.b.22097
- By:
- Publication type:
- Article
Flow cytometric assessment for minimal/measurable residual disease in B lymphoblastic leukemia/lymphoma in the era of immunotherapy.
- Published in:
- Cytometry. Part B, 2023, v. 104, n. 3, p. 205, doi. 10.1002/cyto.b.22113
- By:
- Publication type:
- Article
Abnormal B‐lymphoblasts in myelodysplastic syndromes and myeloproliferative neoplasms other than chronic myeloid leukemia.
- Published in:
- Cytometry. Part B, 2023, v. 104, n. 3, p. 243, doi. 10.1002/cyto.b.22047
- By:
- Publication type:
- Article
PD‐1 improves accurate detection of Sezary cells by flow cytometry in peripheral blood in mycosis fungoides/Sezary syndrome.
- Published in:
- Cytometry. Part B, 2022, v. 102, n. 3, p. 189, doi. 10.1002/cyto.b.22070
- By:
- Publication type:
- Article
14‐Color single tube for flow cytometric characterization of CD5+ B‐LPDs and high sensitivity automated minimal residual disease quantitation of CLL/SLL.
- Published in:
- Cytometry. Part B, 2021, v. 100, n. 4, p. 509, doi. 10.1002/cyto.b.21953
- By:
- Publication type:
- Article
Case study interpretation-Portland: Case 2.
- Published in:
- Cytometry. Part B, 2012, v. 82B, n. 3, p. 180, doi. 10.1002/cyto.b.21013
- By:
- Publication type:
- Article
Flow cytometric detection of the classical hodgkin lymphoma: clinical and research applications.
- Published in:
- 2011
- By:
- Publication type:
- Journal Article
Flow Cytometric Detection of the Classical Hodgkin Lymphoma: Clinical and Research Applications.
- Published in:
- Advances in Hematology, 2011, v. 2011, p. 1, doi. 10.1155/2011/387034
- By:
- Publication type:
- Article
Rational design of novel red-shifted BRET pairs: Platforms for real-time single-chain protease biosensors.
- Published in:
- Biotechnology Progress, 2009, v. 25, n. 2, p. 559, doi. 10.1002/btpr.144
- By:
- Publication type:
- Article
19‐color, 21‐Antigen Single Tube for Efficient Evaluation of B‐ and T‐cell Neoplasms.
- Published in:
- Current Protocols, 2023, v. 3, n. 9, p. 1, doi. 10.1002/cpz1.884
- By:
- Publication type:
- Article
Minimal/Measurable Disease Analysis in Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma by Flow Cytometry.
- Published in:
- Current Protocols, 2022, v. 2, n. 8, p. 1, doi. 10.1002/cpz1.503
- By:
- Publication type:
- Article
Hairy cell leukemia expresses programmed death-1.
- Published in:
- 2020
- By:
- Publication type:
- Letter
Bright PD-1 expression by flow cytometry is a powerful tool for diagnosis and monitoring of angioimmunoblastic T-cell lymphoma.
- Published in:
- 2020
- By:
- Publication type:
- Letter
Comparison of MALDI‐TOF mass spectrometry analysis of peripheral blood and bone marrow‐based flow cytometry for tracking measurable residual disease in patients with multiple myeloma.
- Published in:
- British Journal of Haematology, 2020, v. 189, n. 5, p. 904, doi. 10.1111/bjh.16443
- By:
- Publication type:
- Article
Role of Flow Cytometric Immunophenotyping for Classic Hodgkin Lymphoma in Small Biopsy and Cytology Specimens.
- Published in:
- Archives of Pathology & Laboratory Medicine, 2022, v. 146, n. 4, p. 462, doi. 10.5858/arpa.2020-0795-OA
- By:
- Publication type:
- Article
Single-Tube 10-Fluorochrome Analysis for Efficient Flow Cytometric Evaluation of Minimal Residual Disease in Plasma Cell Myeloma.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Infection with an Endemic Human Herpesvirus Disrupts Critical Glial Precursor Cell Properties.
- Published in:
- Journal of Neuroscience, 2004, v. 24, n. 20, p. 4875, doi. 10.1523/JNEUROSCI.5584-03.2004
- By:
- Publication type:
- Article
TP63 fusions drive multicomplex enhancer rewiring, lymphomagenesis, and EZH2 dependence.
- Published in:
- Science Translational Medicine, 2023, v. 15, n. 714, p. 1, doi. 10.1126/scitranslmed.adi7244
- By:
- Publication type:
- Article
Baseline identification of clonal V(D)J sequences for DNA-based minimal residual disease detection in multiple myeloma.
- Published in:
- PLoS ONE, 2019, v. 14, n. 3, p. 1, doi. 10.1371/journal.pone.0211600
- By:
- Publication type:
- Article
A 24-Year-Old Man with Previously Diagnosed Hemophilia.
- Published in:
- Clinical Chemistry, 2012, v. 58, n. 7, p. 1086, doi. 10.1373/clinchem.2011.166728
- By:
- Publication type:
- Article
Optimization of plasma fluorogenic thrombin-generation assays.
- Published in:
- American Journal of Clinical Pathology, 2009, v. 132, n. 2, p. 169, doi. 10.1309/AJCP6AY4HTRAAJFQ
- By:
- Publication type:
- Article
Multilineage involvement in KMT2A‐rearranged B acute lymphoblastic leukaemia: cell‐of‐origin, biology, and clinical implications.
- Published in:
- Histopathology, 2024, v. 85, n. 2, p. 310, doi. 10.1111/his.15203
- By:
- Publication type:
- Article
The t(11;14)(q13;q32)/CCND1–IGH translocation in chronic lymphocytic leukaemia/small lymphocytic lymphoma: an unusual genetic aberration during the natural clinical course.
- Published in:
- Histopathology, 2019, v. 75, n. 2, p. 291, doi. 10.1111/his.13885
- By:
- Publication type:
- Article